Sanada Yu

Affiliation and department：

Research field (1)： Molecular biology

Research theme for competitive and other funds (4)：

2024 - 2027 Biguanide系薬剤Metforminの腫瘍内環境特性による細胞致死と抗腫瘍免疫誘導の解析
2019 - 2023 二重特異性抗体を用いたBNCTホウ素デリバリーシステムの開発
2019 - 2023 Interrelationship analysis of the characteristics of quiescent tumor cells with tumor heterogeneity and cancer stem cell nature, referring to application to cancer therapy
2015 - 2018 An attempt to achieve both controlling local tumors and repressing distant metastases through exploiting analytical findings concerning characteristics of intratumor microenvironment

Papers (28)：

Riku Kawasaki, Ayano Oshige, Nanami Kono, Keita Yamana, Hidetoshi Hirano, Yamato Miura, Ryuji Yorioka, Kaori Bando, Anri Tabata, Naoki Yasukawa, et al. Extracellular Vesicles Comprising Carborane Prepared by a Host Exchanging Reaction as a Boron Carrier for Boron Neutron Capture Therapy. ACS applied materials & interfaces. 2024
Riku Kawasaki, Ayano Oshige, Keita Yamana, Hidetoshi Hirano, Kotaro Nishimura, Yamato Miura, Ryuji Yorioka, Yu Sanada, Kaori Bando, Anri Tabata, et al. HER-2-targeted Boron Neutron Capture Therapy with Carborane-integrated Immunoliposomes Prepared via an Exchanging Reaction. Chemistry (Weinheim an der Bergstrasse, Germany). 2023. e202302486
Davide Perico, Ying Tong, Lichao Chen, Shoji Imamichi, Yu Sanada, Masamichi Ishiai, Minoru Suzuki, Mitsuko Masutani, Pierluigi Mauri. Proteomic Characterization of SAS Cell-Derived Extracellular Vesicles in Relation to Both BPA and Neutron Irradiation Doses. Cells. 2023. 12. 12
Riku Kawasaki, Hidetoshi Hirano, Keita Yamana, Ayano Oshige, Kotaro Nishimura, Nanami Kono, Yu Sanada, Kaori Bando, Anri Tabata, Naoki Yasukawa, et al. Phospholipid-Coated Boronic Oxide Nanoparticles as a Boron Agent for Boron Neutron Capture Therapy. ChemBioChem. 2023
Davide Perico, Dario Di Silvestre, Shoji Imamichi, Yu Sanada, Mitsuko Masutani, Pier Luigi Mauri. Systems Biology Approach to Investigate Biomarkers, Boron-10 Carriers, and Mechanisms Useful for Improving Boron Neutron Capture Therapy. Cancer biotherapy & radiopharmaceuticals. 2023. 38. 3. 152-159

ｍore...

MISC (76)：

Tong Ying, Gao Zhongming, Imamichi Shoji, Sanada Yu, 佐々木由香, 野崎中成, Suzuki Minoru, Masunaga Shinichiro, 益谷美都子. BNCT後の早期反応バイオマーカーとしてのHMGB1の動的プロファイル(Dynamic profile of HMGB1 as a biomarker for the early response after BNCT). 日本癌学会総会記事. 2023. 82回. 2156-2156
平野英寿, 河崎陸, 山名啓太, 真田悠生, 坂東香里, 田畑杏梨, 高田卓志, 櫻井良憲, 鈴木実, 樽谷直紀, et al. Development and evaluation of hybrid nanogels composing of carborane-containing polysaccharides and hydrophobic boron oxide nanoparticles for BNCT. 日本バイオマテリアル学会大会予稿集(Web). 2023. 45th
TONG Ying, CHEN Lichao, CHEN Lichao, GAO Zhongming, IMAMICHI Shoji, IMAMICHI Shoji, IMAMICHI Shoji, SANADA Yu, SASAKI Yuka, NOZAKAI Tadashige, et al. The role of GM-CSF in the early response to BNCT. 日本分子生物学会年会プログラム・要旨集(Web). 2023. 46th
GAO Zhongming, TONG Ying, IMAMICHI Shoji, IMAMICHI Shoji, IMAMICHI Shoji, SANADA Yu, SUZUKI Minoru, 石合正道, 石合正道, MASUNAGA Shinichiro, et al. The biological analysis of noncoding RNA SNHG12 after boron neutron capture therapy (BNCT). 日本癌学会学術総会抄録集(Web). 2023. 82nd
真田悠生, 高田卓志, 田中浩基, 櫻井良憲, 渡邉翼. Attempts to enhance the anti-tumor effects of BNCT by targeting the tumor microenvironment. KURNS-EKR (Web). 2023. 17

ｍore...

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page